Prevalence and coincidence of hypertension and orthostatic hypotension in pre- and centenarians and their effect on mortality: preliminary results of Moscow centenarian study

Objective. To estimate the prevalence and impact on mortality of arterial hypertension (HTN) and orthostatic hypotension (OH) in centenarians (95 years and older) in Moscow.

Design and methods. The study participants were 82 super-long-livers of Moscow city aged 95 years and older (minimum age of 95 years, maximum 105 years), who underwent a comprehensive geriatric assessment at home by a multidisciplinary team (geriatrician, nurse and social worker). The following prospective observation lasted for three years (36 months).

Results. Past medical history of HTN was noted in 78 %. The mean systolic blood pressure (SBP) in the supine position was 151 ± 27,9 mm Hg (100–216 mm Hg), and the diastolic blood pressure (DBP) 74 ± 12,8 mm Hg (44–197 mm Hg). OH was detected in 31 % of 61 long-livers who was able to perform an orthostatic test. The presence of OH was not associated with the higher intake of antihypertensive drugs. Within three years, 44 study participants died. The level of blood pressure (BP), history of HTN, and the presence of OH did not affect mortality (p > 0,05).

Conclusions. Centenarians have a wide range of SBP and DBP, high prevalence of HTN and OH. BP level, presence of HTN and OH did not affect mortality over 3 year period. Further investigation is needed to understand better the health status of long-livers and factors affecting the prognosis.

1. World Health Organisation (WHO). Global Health Observatory (GHO) data. Raised blood pressure. [Electronic resource]. URL: https://www.who.int/gho/ncd/risk_factors/blood_pressure_prevalence_text/en/

2. Joffres M, Falaschetti E, Gillespie C, Robitaille C, Loustalot F, Poulter N et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open. 2013;3(8):e003423. doi:10.1136/bmjopen-2013-003423

3. Saedon NI, Tan MP, Frith J. The prevalence of orthostatic hypotension: a systematic review and meta-analysis. Gerontol A Biol Sci Med Sci. 2020;75(1):117–122. doi:10.1093/gerona/gly188

4. Aronow WS, Fleg JL, Pepine CJ, Artinian NT, Bakris G, Brown AS et al. ACCF Task Force. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation. 2011;123(21):2434–2506. doi: 10.1161/CIR.0b013e31821daaf6. Epub 2011 Apr 25.

5. Masaki KH, Schatz IJ, Burchfiel CM, Sharp DS, Chiu D, Foley D et al. Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program. Circulation. 1998;98(21):2290–2295.

6. Di Stefano C, Milazzo V, Totaro S, Sobrero G, Ravera A, Milan A et al. Orthostatic hypotension in a cohort of hypertensive patients referring to a hypertension clinic. J Hum Hypertens. 2015;29(10):599–603. doi:10.1038/jhh.2014.130

7. Ostroumova OD, Cherniaeva MS, Petrova MM, Golovina OV. Orthostatic hypotension: definition, pathophysiology, classification, prognostic aspects, diagnostics and treatment. Rational Pharmacotherapy in Cardiology. 2018;14(5):747–756. doi. org/10.20996/1819-6446-2018-14-5-747-756. In Russian.

8. Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet. 2009;374(9696):1196–1208. doi:10.1016/S0140-6736(09)61460-4

9. Crimmins EM. Lifespan and healthspan: past, present, and promise. Gerontologist. 2015;55(6):901–911. doi:10.1093/geront/gnv130

10. Franceschi C, Passarino G, Mari D, Monti D. Centenarians as a 21st century healthy aging model: A legacy of humanity and the need for a world-wide consortium (WWC100+). Mech Ageing Dev. 2017;165(PtB):55–58. doi:10.1016/j.mad.2017.06.002.

11. Evert J, Lawler E, Bogan H, Perls T. Morbidity profiles of centenarians: survivors, delayers, and escapers. J Gerontol A Biol Sci Med Sci. 2003;58(3):232–237.

12. Schatz IJ, Masaki K, Yano K, Chen R, Rodriguez BL, Curb JD. Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet. 2001;358(9279):351–355.

13. Schupf N, Costa R, Luchsinger J, Tang MX, Lee JH, Mayeux R. Relationship between plasma lipids and all-cause mortality in nondemented elderly. J Am Geriatr Soc. 2005;53(2): 219–226.

14. Oates DJ, Berlowitz DR, Glickman ME, Silliman RA, Borzecki AM. Blood pressure and survival in the oldest old. J Am Geriatr Soc. 2007;55(3):383–388. doi:10.1111/j.1532–5415.2007.01069.x

15. Denardo SJ, Gong Y, Nichols WW, Messerli FH, Bavry AA, Cooper-Dehoff RM et al. Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST Substudy. Am J Med. 2010;123(8):719–726. doi:10.1016/j.amjmed.2010.02.014